Advent International completes takeover of Zentiva

Global private equity firm Advent International completed the acquisition of Sanofi’s European generic business Zentiva for €1.9bn.

Advent will support the Zentiva management team to invest in the company’s operations, production facilities and R&D pipeline, the private equity company said.

Zentiva is present in 50 markets, with a strong focus on Eastern Europe, especially the Czech Republic, Slovakia and Romania.